Antares Pharma, Inc. (ATRS)

EBITDA Margin

33.11%

TTM · Period ending:

ATRS logo

ATRS EBITDA Margin

Latest reported33.11%
ATRS EBITDA Margin (-55.80% → 33.11%)
High-resolution chart · PNG

ATRS ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
35.9666%
10.9192%
3.2931%
-1.756%
-24.2429%
-42.8519%
-41.4253%
-127.9259%
-98.2055%
-49.5953%
-25.6333%
-46.0108%
-113.4742%
-201.1312%
-73.8342%
-178.1251%
-358.8777%
-275.7583%
-818.7171%
-239.1129%
-255.4348%
-224.1664%
-93.1139%
-188.0402%
-71.178%
-55.8004%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.